Abstract | INTRODUCTION: PATIENTS AND METHODS: RESULTS: CONCLUSIONS: P-OM3 supplementation, with or without ERN, was associated with differentially altered lipoprotein fatty acid composition and improved blood pressure parameters.
|
Authors | Alicia H Augustine, Lisa M Lowenstein, William S Harris, Gregory C Shearer, Robert C Block |
Journal | Prostaglandins, leukotrienes, and essential fatty acids
(Prostaglandins Leukot Essent Fatty Acids)
2014 Feb-Mar
Vol. 90
Issue 2-3
Pg. 69-75
ISSN: 1532-2823 [Electronic] Scotland |
PMID | 24378016
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier Ltd. All rights reserved. |
Chemical References |
- Ethyl Ethers
- Fatty Acids
- Fatty Acids, Omega-3
- Lipoproteins
|
Topics |
- Adult
- Aged
- Dietary Supplements
- Ethyl Ethers
(pharmacology, therapeutic use)
- Fatty Acids
(metabolism)
- Fatty Acids, Omega-3
(pharmacology, therapeutic use)
- Female
- Humans
- Insulin Resistance
- Lipid Metabolism
(drug effects)
- Lipoproteins
(metabolism)
- Male
- Middle Aged
- Obesity
(diet therapy, metabolism)
- Overweight
(diet therapy, metabolism)
|